摘要 |
The present invention relates to a group of thiazole derivatives, to methods for the preparation of these compounds, to pharmaceutical compositions containing at least one these compounds as active ingredient, as well to the use of these compositions for the treatment of psychiatric and neurological disorders and other diseases involving cannabinoid CB neurotransmission. The thiazole derivatives of the invention are either cannabinoid (CB) receptor antagonists, CB receptor agonists, CB receptor inverse agonists or CB receptor partial agonists. The compounds have the general formula (I) wherein R, R1 and X have the meanings given in the specification. |